Neurological Biomarkers Market: Rapid Growth, Key Players and Trends, CAGR 13.7% by 2029

Neurological Biomarkers Market set to approach $19.96 billion, driven by prevalence of neurological disorders, technology advancements and increased funding for neurological research.

What Is The Projected Market Size Of The Global Neurological Biomarkers Market And Its Growth Rate?
• Growth from $10.7 billion in 2024 to $11.96 billion in 2025 at a CAGR of 11.7%.
• Estimated growth to $19.96 billion in 2029 at a CAGR of 13.7%.
• Factors contributing to growth: increasing prevalence of neurological disorders, aging population, drug development needs, increased funding for neurological research, and personalized medicine.

What Is Driving The Growth In The Neurological Biomarkers Market?
The growth of the neurological biomarker market is primarily driven by the increasing prevalence of neurological diseases. These diseases have an impact on the brain, spinal cord, and nerves in the body. Parkinson's disease, a debilitating neurological disorder, can be diagnosed early through the use of biomarkers, amplifying the market's growth. For instance, diagnoses of Parkinson's disease in the US rose to 90,000 in 2022, a significant increase from 60,000 in 2021, according to the Parkinson's Foundation.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12677&type=smp

Who Are the Key Players Driving Neurological Biomarkers Market Growth?
• Pfizer Inc.
• F. Hoffmann-La Roche AG
• Merck & Co. Inc.
• Novartis AG
• Thermos Fisher Scientific Inc.
• AstraZeneca Plc
• Abbott Laboratories
• Boehringer Ingelheim International GmbH
• Becton Dickinson and Company
• Agilent Technologies Inc.

What Are The Key Trends In The Neurological Biomarkers Market?
• Technological innovation in imaging.
• Rapid advances in omics technologies.
• Integration of Artificial Intelligence (AI).
• Real-world evidence in biomarker validation.
• Advancements in diagnostic technologies.
• Collaboration between industry and research institutions.

What Are The Segments Of The Global Neurological Biomarkers Market?
1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products
2) By Application: Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy
3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users

Which Region Leads The Neurological Biomarkers Market?
North America was the largest region in the neurological biomarkers market in 2024. The regions covered in the report also include Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report

What Is Covered In The Neurological Biomarkers Market Global Market Report?
- Market Size Analysis
- Market Segmentation Analysis
- Key Player Focus
- Growth Trends Analysis
- Market Contribution
- Growth Drivers
- Industry Challenges
- Competitive Developments

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=12677&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.